about
The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardiiSaccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tractImmunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantumLuciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitroInduction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors.Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability.The Staphylococcus aureus epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia.Escherichia coli α-hemolysin counteracts the anti-virulence innate immune response triggered by the Rho GTPase activating toxin CNF1 during bacteremia.EDIN-B Promotes the Translocation of Staphylococcus aureus to the Bloodstream in the Course of Pneumonia.Bacteria and the ubiquitin pathway.High prevalence of edin-C encoding RhoA-targeting toxin in clinical isolates of Staphylococcus aureus.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxinActivation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response.Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.Diet Supplementation in ω3 Polyunsaturated Fatty Acid Favors an Anti-Inflammatory Basal Environment in Mouse Adipose Tissue
P50
Q24294840-E7131DB9-BAE5-412F-81B5-9140A23F54C9Q27306197-563C7421-B1B1-4264-80AC-4D610693A509Q27318236-FF7A542C-1E93-485F-98D2-8E830D3FBBD9Q27342880-21CDCFB7-CDDF-4B3E-8F94-E2599DACC6D5Q28477052-6C48FA80-3854-47C9-9776-208518C2101EQ30480409-D883BA74-6246-4E68-8995-2CA6ABC4DEE9Q30489997-4324097A-881B-4498-BB6C-E730F08DED51Q34045066-0E07EA2E-3BFE-45C2-B012-B5C91B74516BQ35187869-2E18FCCC-6FFB-442B-85FB-CD03040E4D61Q36226869-E1544BC6-8830-4C18-B463-AEF20D201E58Q36678179-0D760E50-2BDB-4BA3-AC7B-99152B563EF2Q38337389-B7955B67-DB8F-4EC5-886F-DF7E53C3271BQ38822566-873427C9-4C8E-408B-BCCC-B5E949BF7590Q40554106-026762BA-5C2D-4BDC-A169-842D034235F0Q44222769-79134369-4729-4AB2-A61C-E73F66B5D207Q63681528-F18CBD53-D6B7-4E50-993C-144735F9D0CB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrick Munro
@ast
Patrick Munro
@en
Patrick Munro
@es
Patrick Munro
@nl
type
label
Patrick Munro
@ast
Patrick Munro
@en
Patrick Munro
@es
Patrick Munro
@nl
prefLabel
Patrick Munro
@ast
Patrick Munro
@en
Patrick Munro
@es
Patrick Munro
@nl
P106
P31
P496
0000-0003-4283-4671